These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 2908750

  • 21. Reversal of male infertility on changing treatment from sulphasalazine to 5-aminosalicylic acid.
    Cann PA, Holdsworth CD.
    Lancet; 1984 May 19; 1(8386):1119. PubMed ID: 6144844
    [No Abstract] [Full Text] [Related]

  • 22. Leucopenia resulting from a drug interaction between azathioprine or 6-mercaptopurine and mesalamine, sulphasalazine, or balsalazide.
    Lowry PW, Franklin CL, Weaver AL, Szumlanski CL, Mays DC, Loftus EV, Tremaine WJ, Lipsky JJ, Weinshilboum RM, Sandborn WJ.
    Gut; 2001 Nov 19; 49(5):656-64. PubMed ID: 11600468
    [Abstract] [Full Text] [Related]

  • 23. 5-aminosalicylic acid as rectal enema in ulcerative colitis patients unable to take sulphasalazine.
    Campieri M, Lanfranchi GA, Brignola C, Bazzocchi G, Minguzzi MR, Calari MT.
    Lancet; 1984 Feb 18; 1(8373):403. PubMed ID: 6141471
    [No Abstract] [Full Text] [Related]

  • 24. Sulphasalazine-related life-threatening side effects: is N-acetylcysteine of therapeutic value?
    Gabay C, De Bandt M, Palazzo E.
    Clin Exp Rheumatol; 1993 Feb 18; 11(4):417-20. PubMed ID: 8104747
    [Abstract] [Full Text] [Related]

  • 25. Glomerular and tubular renal functions after long-term medication of sulphasalazine, olsalazine, and mesalazine in patients with ulcerative colitis.
    Birketvedt GS, Berg KJ, Fausa O, Florholmen J.
    Inflamm Bowel Dis; 2000 Nov 18; 6(4):275-9. PubMed ID: 11149559
    [Abstract] [Full Text] [Related]

  • 26. [Salicylic derivatives in the clinical treatment of inflammatory bowel disease: new perspectives].
    Damião AO, Sipahi AM.
    Rev Hosp Clin Fac Med Sao Paulo; 1989 Nov 18; 44(5):271-8. PubMed ID: 2576896
    [Abstract] [Full Text] [Related]

  • 27. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM, Greenberg GR.
    Am J Gastroenterol; 1988 Jan 18; 83(1):15-9. PubMed ID: 2892391
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the absorption and metabolism of sulphasalazine and acrylic-coated 5-amino salicylic acid in normal subjects and patients with colitis.
    Dew MJ, Ebden P, Kidwai NS, Lee G, Evans BK, Rhodes J.
    Br J Clin Pharmacol; 1984 Apr 18; 17(4):474-6. PubMed ID: 6144318
    [Abstract] [Full Text] [Related]

  • 29. Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution.
    Riley SA, Lecarpentier J, Mani V, Goodman MJ, Mandal BK, Turnberg LA.
    Gut; 1987 Aug 18; 28(8):1008-12. PubMed ID: 2889648
    [Abstract] [Full Text] [Related]

  • 30. Salicylate induced exacerbation of ulcerative colitis.
    Chakraborty TK, Bhatia D, Heading RC, Ford MJ.
    Gut; 1987 May 18; 28(5):613-5. PubMed ID: 3596343
    [Abstract] [Full Text] [Related]

  • 31. A pharmacokinetic study of sulphasalazine and two new formulations of mesalazine.
    Swift GL, Mills CM, Rhodes J, Evans BK, Bennett A, Tavares IA.
    Aliment Pharmacol Ther; 1992 Apr 18; 6(2):259-66. PubMed ID: 1350926
    [Abstract] [Full Text] [Related]

  • 32. [Leukopenia in a patient successively treated with sulfasalazine and mesalazine].
    Bodin F, Biour M, Grange JD.
    Therapie; 1991 Apr 18; 46(4):341. PubMed ID: 1683025
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Acute hepatitis due to para-aminosalicylic acid.
    Sochocky S.
    Br J Clin Pract; 1971 Apr 18; 25(4):179-82. PubMed ID: 5575913
    [No Abstract] [Full Text] [Related]

  • 35. Sulphasalazine induced hepatitis in juvenile rheumatoid arthritis.
    Caspi D, Fuchs D, Yaron M.
    Ann Rheum Dis; 1992 Feb 18; 51(2):275-6. PubMed ID: 1347987
    [Abstract] [Full Text] [Related]

  • 36. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
    Nakajima H, Munakata A, Yoshida Y.
    J Gastroenterol; 1995 Nov 18; 30 Suppl 8():115-7. PubMed ID: 8563870
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of leucocyte motility by drugs used in ulcerative colitis.
    Rhodes JM, Bartholomew TC, Jewell DP.
    Gut; 1981 Aug 18; 22(8):642-7. PubMed ID: 6116649
    [Abstract] [Full Text] [Related]

  • 38. Sulfasalazine, 5-ASA and acute pancreatitis in crohn's disease.
    Debongnie JC, Dekoninck X.
    J Clin Gastroenterol; 1994 Dec 18; 19(4):348-9. PubMed ID: 7876525
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Hepatotoxic effect of ethionamide and para-amino-salicylic acid in initial chemotherapy of patients with pulmonary tuberculosis in the light of liver function tests].
    Pruszyńska S.
    Gruzlica; 1971 Dec 18; 39(12):1211-8. PubMed ID: 5139240
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.